Medios

Medios Dividend

Dividend of Medios (ILM1.DE) as of Oct 28, 2026.

Dividend

0.00EUR

Last updated:

How much dividend does Medios 2026 pay?

According to the latest status from October 2026, Medios paid a total of 0.00 EUR per share in dividends within the last 12 months. With the current Medios price of 10.34 EUR, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Medios Dividends

Historical Medios Dividends
PaydateDividend

The Medios Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2024
0.00 EUR
Jan 1, 2025
0.00 EUR
Jan 1, 2026 (e)
0.00 EUR
Jan 1, 2027 (e)
0.00 EUR
Jan 1, 2028 (e)
0.00 EUR
Jan 1, 2029 (e)
0.00 EUR
Jan 1, 2030 (e)
0.00 EUR
Jan 1, 2031 (e)
0.00 EUR
The Medios Dividend history
YEARDividendYoY
est0.00EUR—
est0.00EUR—
est0.00EUR—
est0.00EUR—
est0.00EUR—
est0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—

Is the Medios Dividend Safe?

Medios has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Medios's Dividend Distributions

Medios’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Medios's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Medios's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Medios’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Medios Stock analysis

What does Medios do? Medios AG is a leading company in the supply of high-quality specialty preparations to patients. The company was founded in Berlin in 2004 and has been listed on the Frankfurt Stock Exchange since 2018. Medios AG quickly achieved a strong position in the German healthcare market and currently employs approximately 300 employees at multiple locations in Germany. The business model of Medios AG is based on the production and distribution of high-quality specialty preparations. These are developed and produced in close collaboration with customers such as hospitals and outpatient clinics. Medios AG's products are typically used to treat rare and chronic diseases, such as immunological diseases, cancer, and metabolic disorders. Medios AG offers a wide range of products and services. The company is divided into three areas. The first area is Medios AG's core business, the distribution of specialty preparations. This area includes the development, production, and distribution of specialty preparations. The portfolio includes, for example, medications for pain and inflammation, as well as preparations for the treatment of Parkinson's and Alzheimer's diseases. Another important aspect in the field of specialty preparations is the supply of patients with parenteral nutrition solutions. These are used in both outpatient and inpatient settings to provide care for patients with severe diseases. The second area is supply services. Here, Medios offers a comprehensive range of services to support customers in hospital care and outpatient patient care. An important aspect of this area is the support of hospitals in dealing with delegations. For example, training is offered to educate hospital staff on the management of certain diseases. The third area is clinical study support. Medios AG offers services and products to support customers in clinical studies. The range includes criteria for patient-related logistics, the delivery of placebos and blinded medications, as well as specialty preparations and parenteral nutrition solutions. In each of these areas, Medios brings its high expertise and experience to develop the best possible solutions for customers and patients. Overall, Medios AG has established itself as an important partner for the German healthcare sector. The company pursues a clear strategy focused on the development and production of specialty preparations for the treatment of serious and rare diseases. The company places the highest value on the quality and safety of its products, as well as comprehensive consultation and customer care. Medios has a strong network of partners and suppliers in the healthcare industry and is a respected contact for customers and other market participants due to its experience and expertise. Medios is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medios stock

Medios paid dividends every year for the past 0 years.

Medios is assigned to the 'Health' sector.

The dividends of Medios are distributed in EUR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Medios